Balanced news tone
News Sentiment
COIL sentiment intelligence
Coiled Therapeutics plc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
News tone and price action are not far from neutral.
92/100 classification confidence.
directly relevant articles
high-authority source matches
+2.6% over one week, -7.1% over four weeks, trend inactive, and below fair value.
Coiled Therapeutics develops improved formulation of experimental cancer drug ahead of trial expansion
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Coiled Therapeutics develops improved formulation of experimental cancer drug ahead of trial expansion
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 07 Jul 2026 06:24
- Source
- Proactive Investors
Coiled Therapeutics appoints biotech veteran Craig Tooman to board
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 24 Jun 2026 07:00
- Source
- Market source
REG - Coiled Therapeutics - Grant of Share Options
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 17 Jun 2026 07:00
- Source
- TradingView
Coiled Therapeutics strengthens its scientific bench
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 07 Jun 2026 07:00
- Source
- Market source
Coiled Therapeutics begins trading on US OTCQB market to broaden investor base
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 19 May 2026 07:00
- Source
- Market source
EnergyPathways, Coiled Therapeutics, Zanaga Iron Ore, Seeing Machines, QBT, Union Jack Oil
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 06 May 2026 07:00
- Source
- Proactive Investors
Coiled Therapeutics targets cancer partnering deals after promising trial data
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 06 May 2026 07:00
- Source
- Market source
PureTech Health shares boosted as investee Seaport Therapeutics prices Nasdaq IPO
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 01 May 2026 07:00
- Source
- Market source
PureTech’s Seaport Therapeutics Prices Enlarged $254.9 Million Nasdaq IPO
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 01 May 2026 07:00
- Source
- Market source
Sunda Energy, Union Jack Oil, Solvonis, Coiled Therapeutics, Frontier IP, Quantum Blockchain
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 08 Apr 2026 07:00
- Source
- Proactive Investors
COIL Stock Price and Chart — LSE:COIL
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Apr 2026 00:55
- Source
- TradingView
Roquefort Therapeutics (COIL) Share Price, Stock Value, News & Analysis $COIL
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 01 Apr 2026 02:55
- Source
- MarketBeat
Roquefort Therapeutics to acquire cancer drug licence in £32m RTO deal and raise £8.5m
- Tone
- Positive 66/100
- Event
- Deals and strategy
- Published
- 02 Mar 2026 08:00
- Source
- Proactive Investors